GT BIOPHARMA, INC. Conversion of Stock, Shares Issued
GT BIOPHARMA, INC. (GTBP) reported Conversion of Stock, Shares Issued of 74.09 thousand shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2022-03-28
- GT BIOPHARMA, INC. conversion of stock, shares issued for the quarter ending 2021-09-30 was -2.24M shares.
- GT BIOPHARMA, INC. conversion of stock, shares issued for fiscal 2020 was 511.88K shares.
| Period end | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 6 month | Conversion of Stock, Shares Issued 9 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|
| 2021-09-30 | -2.24M shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-10 | 74.09K shares 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | 2.31M shares 10-Q/A · filed 2021-12-29 | |||
| 2020-12-31 | 511.88K shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |